MeMed - COVID-19 Severity Test Devices
Some infections resolve quickly, while others lead to severe immune dysregulation, respiratory failure and death. Distinguishing between the two is challenging.MeMed COVID-19 Severity builds on an extensive body of evidence supporting the role of viral-induced TRAIL and IP-10 and inflammatory CRP proteins in severe SARS-CoV-2 infection. From a small serum sample, MeMed COVID-19 Severity computationally integrates the levels of these three host immune proteins into a simple score indicating the likelihood of patient deterioration.
Conventional tests are important, but insufficient to aid in effective patient management:
- Inaccurate risk stratification
- Fail to alert prior to organ damage
- Uncertainty regarding results interpretation
- Prolonged turnaround time
- Unable to capture
- disease complexity
Predictive
- Early indication of deterioration
- Predictive of further disease progression vs. recovery
Actionable
- Ease of use: single serum sample per test
- 15 minutes from sample to result
- Easy to interpret results
MeMed Key is a cutting edge, compact immunoassay platform that makes it possible to conduct highly sensitive, multiplexed protein measurements that previously could only be done on expensive central lab equipment.
MeMed BV, MeMed Key & MeMed COVID-19 Severity are CE Marked.